Free Trial

Paysign (PAYS) Financials

Paysign logo
$15.60 +0.44 (+2.90%)
Closing price 04:00 PM Eastern
Extended Trading
$15.23 -0.37 (-2.40%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Paysign

Annual Income Statements for Paysign

This table shows Paysign's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-2.41 1.40 1.79 2.59 7.45 -9.14 -2.72 1.03 6.46 3.82 7.55
Consolidated Net Income / (Loss)
-2.55 1.30 1.79 2.58 7.45 -9.14 -2.72 1.03 6.46 3.82 7.55
Net Income / (Loss) Continuing Operations
-2.55 1.30 1.79 2.58 7.45 -9.14 -2.72 1.03 6.46 3.82 7.55
Total Pre-Tax Income
-2.55 1.30 1.79 2.58 6.54 -8.25 -2.71 1.14 2.36 4.14 10
Total Operating Income
-0.01 1.36 1.77 2.47 6.10 -8.34 -2.74 0.34 -0.17 1.02 7.36
Total Gross Profit
4.09 4.54 6.70 11 19 9.30 15 21 24 32 49
Total Revenue
8.11 10 15 23 35 24 29 38 47 58 82
Operating Revenue
8.11 10 15 23 35 24 29 38 47 58 82
Total Cost of Revenue
4.02 5.88 8.53 12 15 15 15 17 23 26 33
Operating Cost of Revenue
4.02 5.88 8.53 12 15 15 15 17 23 26 33
Total Operating Expenses
4.10 3.18 4.93 8.92 13 18 17 21 24 31 41
Selling, General & Admin Expense
3.73 2.61 4.06 7.84 12 15 15 18 20 25 33
Depreciation Expense
0.36 0.57 0.88 1.09 1.48 2.12 2.50 2.91 4.03 5.99 8.32
Total Other Income / (Expense), net
-2.54 -0.06 0.02 0.11 0.44 0.09 0.03 0.79 2.53 3.12 2.67
Interest & Investment Income
- - - 0.14 0.44 0.09 0.03 0.79 2.53 3.12 2.67
Income Tax Expense
0.00 0.00 0.01 0.00 -0.91 0.89 0.01 0.11 -4.09 0.32 2.48
Basic Earnings per Share
($0.06) $0.04 $0.04 $0.06 $0.16 - ($0.05) $0.02 $0.12 $0.07 $0.14
Weighted Average Basic Shares Outstanding
39.64M 42.88M 43.40M 45.45M 47.44M 49.27M 50.98M 52.05M 52.49M 53.21M 54.43M
Diluted Earnings per Share
$0.00 $0.03 $0.04 $0.05 $0.14 - ($0.05) $0.02 $0.12 $0.07 $0.13
Weighted Average Diluted Shares Outstanding
0.00 43.87M 48.04M 51.99M 54.55M 49.27M 50.98M 52.93M 54.16M 55.59M 59.65M
Weighted Average Basic & Diluted Shares Outstanding
42.77M 43.19M 43.67M 46.73M 49.01M 50.45M 51.86M 52.46M 52.97M 53.75M 55.19M

Quarterly Income Statements for Paysign

This table shows Paysign's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
5.62 0.31 0.70 1.44 1.37 2.59 1.39 2.22 1.36 5.44 6.76
Consolidated Net Income / (Loss)
5.62 0.31 0.70 1.44 1.37 2.59 1.39 2.22 1.36 5.44 6.76
Net Income / (Loss) Continuing Operations
5.62 0.31 0.70 1.44 1.37 2.59 1.39 2.22 1.36 5.44 6.76
Total Pre-Tax Income
1.36 0.47 0.94 1.49 1.24 3.25 2.04 2.25 2.49 7.47 7.91
Total Operating Income
0.63 -0.26 0.13 0.69 0.46 2.49 1.44 1.58 1.85 6.67 7.01
Total Gross Profit
7.14 6.94 7.59 8.47 9.20 12 12 12 13 18 18
Total Revenue
14 13 14 15 16 19 19 22 23 28 28
Operating Revenue
14 13 14 15 16 19 19 22 23 28 28
Total Cost of Revenue
6.55 6.25 6.75 6.78 6.41 6.91 7.32 9.45 9.63 9.82 10
Operating Cost of Revenue
6.55 6.25 6.75 6.78 6.41 6.91 7.32 9.45 9.63 9.82 10
Total Operating Expenses
6.51 7.20 7.46 7.78 8.73 9.20 10 11 11 12 11
Selling, General & Admin Expense
5.33 5.91 6.02 6.22 7.03 7.40 8.20 8.38 9.06 8.91 8.55
Depreciation Expense
1.18 1.29 1.44 1.57 1.70 1.80 2.12 2.19 2.21 2.64 2.34
Total Other Income / (Expense), net
0.73 0.73 0.81 0.80 0.77 0.76 0.61 0.66 0.64 0.80 0.89
Interest & Investment Income
0.73 0.73 0.81 0.80 0.77 0.76 0.61 0.66 0.64 0.80 0.89
Income Tax Expense
-4.26 0.16 0.24 0.05 -0.14 0.67 0.66 0.03 1.13 2.03 1.15
Basic Earnings per Share
$0.10 $0.01 $0.01 $0.03 $0.02 $0.05 $0.03 $0.04 $0.02 $0.10 $0.12
Weighted Average Basic Shares Outstanding
52.49M 52.84M 53.01M 53.45M 53.21M 53.58M 54.23M 54.80M 54.43M 55.17M 55.86M
Diluted Earnings per Share
$0.10 $0.01 $0.01 $0.03 $0.02 $0.05 $0.02 $0.04 $0.02 $0.09 $0.11
Weighted Average Diluted Shares Outstanding
54.16M 54.76M 55.86M 56.05M 55.59M 55.14M 57.87M 61.77M 59.65M 61.02M 61.98M
Weighted Average Basic & Diluted Shares Outstanding
52.97M 52.98M 53.14M 53.55M 53.75M 54.22M 54.45M 55.04M 55.19M 55.91M 56.46M

Annual Cash Flow Statements for Paysign

This table details how cash moves in and out of Paysign's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2.50 3.18 5.53 15 14 10 13 21 19 13 43
Net Cash From Operating Activities
-0.72 4.21 7.15 16 17 14 15 25 28 23 52
Net Cash From Continuing Operating Activities
-0.72 4.21 7.15 16 17 14 15 25 28 23 52
Net Income / (Loss) Continuing Operations
-2.41 1.40 1.79 2.59 7.45 -9.14 -2.72 1.03 6.46 3.82 7.55
Consolidated Net Income / (Loss)
-2.41 1.40 1.79 2.59 7.45 -9.14 -2.72 1.03 6.46 3.82 7.55
Depreciation Expense
0.36 0.57 0.88 1.09 1.48 2.12 2.50 2.91 4.03 5.99 8.32
Non-Cash Adjustments To Reconcile Net Income
2.03 -1.01 0.05 1.36 9.29 19 15 2.32 15 22 36
Changes in Operating Assets and Liabilities, net
-0.71 3.24 4.44 11 -1.51 1.95 -0.02 19 2.16 -8.55 0.29
Net Cash From Investing Activities
-0.93 -0.89 -1.52 -1.59 -3.24 -3.34 -2.68 -4.09 -7.05 -9.49 -10
Net Cash From Continuing Investing Activities
-0.93 -0.89 -1.52 -1.59 -3.24 -3.34 -2.68 -4.09 -7.05 -9.49 -10
Purchase of Property, Plant & Equipment
-0.14 -0.11 -0.71 -0.26 -1.96 -3.26 -2.62 -3.91 -7.05 -9.36 -8.01
Acquisitions
-0.79 -0.78 -0.81 -1.34 -1.28 -0.08 -0.06 -0.19 0.00 -0.13 -0.08
Other Investing Activities, net
- - - - - - - - - 0.00 -2.00
Net Cash From Financing Activities
-0.85 -0.14 -0.10 0.10 0.43 -0.07 0.19 0.00 -1.12 -0.47 0.28
Net Cash From Continuing Financing Activities
-0.85 -0.14 -0.10 0.00 0.43 -0.07 0.19 0.00 -1.12 -0.47 0.28
Repurchase of Common Equity
- - - - - - - 0.00 -1.13 -0.50 -0.38
Other Financing Activities, net
- 0.00 0.05 - 0.43 -0.07 0.19 0.00 0.01 0.03 0.66
Cash Income Taxes Paid
- 0.00 0.02 0.01 - 0.00 0.00 0.04 0.21 0.14 0.41

Quarterly Cash Flow Statements for Paysign

This table details how cash moves in and out of Paysign's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
21 5.97 18 -23 12 -11 2.42 4.64 46 15 -3.01
Net Cash From Operating Activities
23 8.24 21 -20 14 -6.03 3.64 6.75 48 19 1.30
Net Cash From Continuing Operating Activities
23 8.24 21 -20 14 -6.03 3.64 6.75 48 19 1.30
Net Income / (Loss) Continuing Operations
5.62 0.31 0.70 1.44 1.37 2.59 1.39 2.22 1.36 5.44 6.76
Consolidated Net Income / (Loss)
5.62 0.31 0.70 1.44 1.37 2.59 1.39 2.22 1.36 5.44 6.76
Depreciation Expense
1.18 1.29 1.44 1.57 1.70 1.80 2.12 2.19 2.21 2.64 2.34
Non-Cash Adjustments To Reconcile Net Income
13 17 -5.42 -1.40 -7.10 -6.35 -1.58 9.87 34 16 -8.66
Changes in Operating Assets and Liabilities, net
4.11 -9.92 24 -22 18 -4.07 1.72 -7.52 10 -5.60 0.86
Net Cash From Investing Activities
-2.05 -2.27 -2.37 -2.45 -2.40 -4.44 -1.81 -2.18 -1.66 -2.08 -1.44
Net Cash From Continuing Investing Activities
-2.05 -2.27 -2.37 -2.45 -2.40 -4.44 -1.81 -2.18 -1.66 -2.08 -1.44
Purchase of Property, Plant & Equipment
-2.05 -2.15 -2.37 -2.45 -2.40 -2.43 -1.80 -2.12 -1.66 -1.68 -1.44
Acquisitions
- -0.12 - - -0.01 -0.01 -0.01 -0.06 0.00 -0.40 -0.01
Net Cash From Financing Activities
- 0.00 0.02 -0.36 -0.13 -0.38 0.59 0.07 - -2.20 -2.87
Net Cash From Continuing Financing Activities
- 0.00 0.02 -0.36 -0.13 -0.38 0.59 0.07 - -2.20 -2.87
Repurchase of Common Equity
- 0.00 - -0.36 -0.13 -0.38 - - - -0.20 0.20
Other Financing Activities, net
- - - 0.00 - 0.00 - 0.07 - -2.00 -3.07
Cash Income Taxes Paid
0.02 0.00 0.07 0.03 0.03 0.00 0.38 0.01 0.02 0.00 1.98

Annual Balance Sheets for Paysign

This table presents Paysign's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
10 14 20 36 54 68 84 108 147 179 276
Total Current Assets
8.72 12 18 33 48 58 74 98 129 159 240
Cash & Equivalents
1.39 1.63 2.75 5.62 9.66 7.83 7.39 9.71 17 11 21
Restricted Cash
7.06 10 14 26 36 48 61 80 92 112 144
Accounts Receivable
0.02 0.11 0.17 0.34 0.89 0.51 4.41 6.12 18 34 72
Prepaid Expenses
0.25 0.27 0.58 1.17 1.41 1.38 1.24 1.70 2.02 2.25 1.95
Other Current Assets
- - - - - - - - - - 0.93
Plant, Property, & Equipment, net
0.27 0.30 0.85 0.88 0.94 1.85 1.64 1.26 1.09 1.16 1.90
Total Noncurrent Assets
1.27 1.56 1.64 2.12 4.73 8.02 8.08 9.27 16 19 34
Goodwill
- - - - - - - - - 0.00 4.49
Intangible Assets
1.26 1.55 1.64 2.12 3.82 3.70 4.09 5.66 8.81 12 22
Noncurrent Deferred & Refundable Income Taxes
- - - 0.01 0.92 - - 0.00 4.30 4.00 1.73
Other Noncurrent Operating Assets
0.00 0.01 - - 0.00 4.32 3.99 3.61 3.22 2.79 5.73
Total Liabilities & Shareholders' Equity
10 14 20 36 54 68 84 108 147 179 276
Total Liabilities
9.08 11 16 27 34 55 71 92 122 149 228
Total Current Liabilities
8.74 11 16 27 34 51 67 89 119 146 216
Short-Term Debt
0.17 0.12 - - - - - - - 0.00 1.86
Accounts Payable
0.59 0.77 1.15 1.33 1.52 2.16 5.77 8.09 27 34 71
Current Deferred Revenue
- - - - 33 48 61 80 92 111 143
Other Current Liabilities
0.92 0.25 - - 0.00 0.32 0.34 0.36 0.38 0.45 0.75
Total Noncurrent Liabilities
0.34 0.03 0.00 0.00 0.00 4.01 3.67 3.31 2.93 2.48 11
Long-Term Debt
0.00 0.03 - - - - - - - 0.00 6.14
Other Noncurrent Operating Liabilities
- - - - 0.00 4.01 3.67 3.31 2.93 2.48 5.27
Commitments & Contingencies
0.00 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1.18 2.70 4.84 8.89 19 13 13 16 24 30 48
Total Preferred & Common Equity
1.27 2.89 5.04 9.10 20 13 13 16 24 30 48
Preferred Stock
- - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1.27 2.89 5.04 9.10 20 13 13 16 24 30 48
Common Stock
6.62 6.84 7.20 8.67 12 14 17 19 22 25 36
Retained Earnings
-5.20 -3.80 -2.01 0.58 8.09 -1.05 -3.77 -2.75 3.71 7.53 15
Treasury Stock
-0.15 -0.15 -0.15 -0.15 -0.15 -0.15 -0.15 -0.15 -1.28 -1.77 -2.15

Quarterly Balance Sheets for Paysign

This table presents Paysign's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
111 173 182 167 205 194 210 313 317
Total Current Assets
99 155 163 147 167 159 171 277 283
Cash & Equivalents
9.94 7.01 31 10 6.85 12 7.53 21 27
Restricted Cash
78 108 102 100 105 102 111 159 149
Accounts Receivable
8.65 37 27 35 53 42 50 94 103
Prepaid Expenses
2.25 2.36 2.47 2.40 2.38 2.41 2.46 3.27 3.03
Other Current Assets
- - - - - - - 0.35 0.35
Plant, Property, & Equipment, net
1.15 1.05 1.11 1.14 1.13 1.12 1.45 2.01 1.95
Total Noncurrent Assets
11 17 18 18 37 34 37 33 32
Goodwill
- - - - 5.51 4.49 4.49 4.49 4.49
Intangible Assets
7.88 9.84 11 12 25 24 23 22 21
Noncurrent Deferred & Refundable Income Taxes
- 4.22 4.08 3.87 3.48 3.33 2.99 1.68 1.38
Other Noncurrent Operating Assets
3.32 3.11 3.01 2.90 2.68 2.57 5.94 5.52 5.31
Total Liabilities & Shareholders' Equity
111 173 182 167 205 194 210 313 317
Total Liabilities
93 148 155 138 166 152 164 258 257
Total Current Liabilities
90 145 153 136 156 143 152 248 248
Short-Term Debt
- - - - 2.00 1.60 1.73 1.59 1.69
Accounts Payable
12 36 50 35 49 39 39 88 98
Current Deferred Revenue
78 108 102 100 104 102 110 158 148
Other Current Liabilities
0.38 0.39 0.40 0.42 0.47 0.49 0.58 0.87 0.89
Total Noncurrent Liabilities
3.03 2.83 2.72 2.60 10 8.37 12 9.60 8.38
Long-Term Debt
- - - - 7.81 6.14 6.14 4.55 3.56
Other Noncurrent Operating Liabilities
3.03 2.83 2.72 2.60 2.36 2.23 5.50 5.05 4.82
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
18 25 27 29 39 42 46 55 60
Total Preferred & Common Equity
18 25 27 29 39 42 46 55 60
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
18 25 27 29 39 42 46 55 60
Common Stock
21 23 23 24 31 33 34 37 38
Retained Earnings
-1.91 4.02 4.72 6.16 10 12 14 21 27
Treasury Stock
-1.28 -1.28 -1.28 -1.64 -2.15 -2.15 -2.15 -2.35 -5.34

Annual Metrics And Ratios for Paysign

This table displays calculated financial ratios and metrics derived from Paysign's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
42,510,765.00 42,948,265.00 43,660,765.00 44,100,765.00 47,923,762.00 49,844,457.00 51,691,932.00 52,246,932.00 52,754,374.00 - 55,042,888.00
DEI Adjusted Shares Outstanding
42,510,765.00 42,948,265.00 43,660,765.00 44,100,765.00 47,923,762.00 49,844,457.00 51,691,932.00 52,246,932.00 52,754,374.00 - 55,042,888.00
DEI Earnings Per Adjusted Shares Outstanding
-0.06 0.03 0.04 0.06 0.16 -0.18 -0.05 0.02 0.12 - 0.14
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.23% 28.48% 46.25% 53.76% 48.00% -30.42% 22.16% 29.08% 24.30% 23.50% 40.50%
EBITDA Growth
-173.64% 190.46% 36.63% 32.73% 114.80% -181.92% 96.11% 1,447.31% 18.60% 81.81% 123.50%
EBIT Growth
-191.41% 154.66% 29.78% 36.85% 149.91% -236.65% 67.15% 112.57% -148.57% 710.75% 620.78%
NOPAT Growth
-100.23% 21,976.35% 29.68% 40.34% 181.09% -183.98% 67.15% 116.26% -246.60% 306.12% 488.32%
Net Income Growth
-197.68% 150.90% 37.61% 44.55% 188.73% -222.66% 70.23% 137.77% 528.42% -40.92% 97.90%
EPS Growth
-100.00% 0.00% 33.33% 25.00% 180.00% 0.00% 0.00% 140.00% 500.00% -41.67% 85.71%
Operating Cash Flow Growth
-123.34% 684.47% 70.07% 123.67% 4.48% -17.57% 10.54% 66.26% 9.10% -16.92% 128.57%
Free Cash Flow Firm Growth
-122.19% 489.85% 74.05% 143.88% -19.19% 2.73% 1.85% 66.83% -40.75% -26.13% 177.33%
Invested Capital Growth
9.84% -23.76% -40.27% -84.82% -15.34% -63.06% -29.99% -32.18% -15.30% -8.29% -18.05%
Revenue Q/Q Growth
-25.54% 9.26% 11.46% 10.64% 9.13% -9.43% 5.41% 5.12% 6.95% 3.39% 9.55%
EBITDA Q/Q Growth
-173.17% 22.05% 1.69% 4.81% 15.01% -46.39% 77.72% 11.30% 22.84% 5.37% 13.74%
EBIT Q/Q Growth
-194.67% 31.43% 3.44% 0.15% 16.49% -33.92% 21.75% 159.43% 65.50% -14.10% 23.27%
NOPAT Q/Q Growth
-100.23% 31.12% 2.69% 1.30% 20.81% -33.92% 21.75% 175.59% -6.89% -58.11% 7.67%
Net Income Q/Q Growth
-5,866.84% 34.19% 4.34% 2.62% 20.05% -210.24% 61.86% 146.21% 316.85% -52.69% -0.14%
EPS Q/Q Growth
-100.00% 200.00% 0.00% 0.00% 27.27% 0.00% 0.00% 0.00% 300.00% -53.33% 0.00%
Operating Cash Flow Q/Q Growth
-122.11% 185.53% 19.83% 37.09% -7.89% -25.51% -11.61% -16.03% 1,996.66% -28.46% 180.89%
Free Cash Flow Firm Q/Q Growth
-115.29% 3,121.96% 29.89% 38.68% -21.46% 9.26% -33.90% -25.35% 184.71% -45.04% 284.62%
Invested Capital Q/Q Growth
19.28% -11.87% -20.61% -33.22% -6.61% -10.34% 3.67% 10.36% -21.60% -11.99% -67.10%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
50.42% 43.56% 43.98% 48.66% 55.50% 38.57% 49.93% 55.09% 51.06% 55.15% 59.39%
EBITDA Margin
-26.55% 18.69% 17.46% 15.07% 21.88% -25.76% -0.82% 8.56% 8.16% 12.02% 19.12%
Operating Margin
-0.11% 13.04% 11.60% 10.56% 17.60% -34.57% -9.30% 0.91% -0.35% 1.75% 8.98%
EBIT Margin
-31.02% 13.20% 11.71% 10.42% 17.60% -34.57% -9.30% 0.91% -0.35% 1.75% 8.98%
Profit (Net Income) Margin
-31.45% 12.46% 11.72% 11.02% 21.50% -37.90% -9.24% 2.70% 13.66% 6.54% 9.21%
Tax Burden Percent
100.00% 100.00% 99.67% 100.00% 113.91% 110.84% 100.38% 90.53% 273.23% 92.21% 75.27%
Interest Burden Percent
101.37% 94.39% 100.43% 105.72% 107.23% 98.91% 98.97% 329.69% -1,413.30% 405.11% 136.27%
Effective Tax Rate
0.00% 0.00% 0.33% 0.00% -13.91% 0.00% 0.00% 9.47% -173.23% 7.79% 24.73%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-128.79% 66.95% 47.38% 37.60% 52.87% -56.19% -20.75% 7.02% 31.68% 13.89% 19.13%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-21.66% 11.39% 10.41% 8.63% 13.60% -13.74% -3.61% 0.36% -0.13% 0.63% 3.23%
Return on Assets (ROA)
-21.96% 10.75% 10.42% 9.12% 16.61% -15.06% -3.58% 1.07% 5.07% 2.34% 3.32%
Return on Common Equity (ROCE)
-130.22% 71.89% 49.86% 38.71% 53.76% -56.65% -20.75% 7.02% 31.68% 13.89% 19.13%
Return on Equity Simple (ROE_SIMPLE)
-200.50% 44.88% 35.42% 28.38% 38.09% -69.07% -20.95% 6.31% 26.38% 12.54% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.01 1.36 1.76 2.47 6.95 -5.84 -1.92 0.31 -0.46 0.94 5.54
NOPAT Margin
-0.08% 13.04% 11.57% 10.56% 20.05% -24.20% -6.51% 0.82% -0.97% 1.61% 6.76%
Net Nonoperating Expense Percent (NNEP)
-26.87% -0.62% 0.17% 0.44% 1.30% -6.50% -1.29% 0.90% 6.94% 2.48% 1.44%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -1.87% 3.09% 9.81%
Cost of Revenue to Revenue
49.58% 56.44% 56.02% 51.34% 44.50% 61.43% 50.07% 44.91% 48.94% 44.85% 40.61%
SG&A Expenses to Revenue
46.06% 25.02% 26.62% 33.45% 33.63% 62.57% 50.75% 46.54% 42.89% 43.13% 40.27%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
50.53% 30.52% 32.37% 38.10% 37.90% 73.14% 59.23% 54.19% 51.41% 53.40% 50.41%
Earnings before Interest and Taxes (EBIT)
-2.52 1.37 1.78 2.44 6.10 -8.34 -2.74 0.34 -0.17 1.02 7.36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.15 1.95 2.66 3.53 7.58 -6.21 -0.24 3.25 3.86 7.02 16
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
8.02 3.57 2.08 17.07 24.86 17.47 6.37 8.27 6.03 5.31 5.85
Price to Tangible Book Value (P/TBV)
1,368.37 7.68 3.08 22.24 30.89 24.25 9.29 12.67 9.42 8.88 13.09
Price to Revenue (P/Rev)
1.26 0.99 0.69 6.63 14.03 9.59 2.81 3.54 3.12 2.77 3.46
Price to Earnings (P/E)
0.00 7.36 5.85 59.98 65.25 0.00 0.00 131.15 22.87 42.38 37.54
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 13.59% 17.09% 1.67% 1.53% 0.00% 0.00% 0.76% 4.37% 2.36% 2.66%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.23 0.00 0.00 5.27 12.71 7.27 0.48 1.18 0.81 0.67 1.54
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 34.94 58.09 0.00 0.00 13.80 9.94 5.61 8.07
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 50.53 72.21 0.00 0.00 130.40 0.00 38.54 17.18
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 49.89 63.39 0.00 0.00 144.03 0.00 41.80 22.83
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 7.71 26.36 12.73 0.92 1.77 1.39 1.72 2.41
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 9.54 42.18 16.34 1.28 2.46 3.55 4.93 5.72
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.15 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17
Long-Term Debt to Equity
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13
Financial Leverage
-4.78 -5.10 -3.80 -3.56 -2.74 -3.12 -4.76 -5.42 -4.89 -4.22 -3.54
Leverage Ratio
5.87 6.23 4.55 4.12 3.18 3.73 5.79 6.57 6.25 5.93 5.77
Compound Leverage Factor
5.95 5.88 4.57 4.36 3.41 3.69 5.73 21.65 -88.32 24.02 7.86
Debt to Total Capital
12.86% 5.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.17%
Short-Term Debt to Total Capital
12.86% 4.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.30%
Long-Term Debt to Total Capital
0.00% 0.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.87%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-6.76% -6.83% -4.13% -2.33% -1.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
93.90% 101.50% 104.13% 102.33% 101.36% 100.00% 100.00% 100.00% 100.00% 100.00% 85.83%
Debt to EBITDA
-0.08 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.51
Net Debt to EBITDA
3.85 -5.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -10.01
Long-Term Debt to EBITDA
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.39
Debt to NOPAT
-28.03 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.44
Net Debt to NOPAT
1,333.14 -8.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -28.33
Long-Term Debt to NOPAT
0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.11
Altman Z-Score
-0.06 1.32 1.44 4.50 10.06 2.60 0.98 1.31 1.16 1.14 1.31
Noncontrolling Interest Sharing Ratio
-1.11% -7.38% -5.24% -2.96% -1.67% -0.81% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.00 1.08 1.15 1.22 1.40 1.15 1.10 1.10 1.08 1.09 1.11
Quick Ratio
0.16 0.16 0.19 0.22 0.31 0.16 0.18 0.18 0.29 0.31 0.43
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-0.78 3.05 5.30 13 10 11 11 18 11 7.98 22
Operating Cash Flow to CapEx
-520.13% 3,827.68% 1,011.24% 6,222.61% 854.41% 422.11% 581.84% 648.07% 391.86% 245.13% 654.75%
Free Cash Flow to Firm to Interest Expense
-22.74 39.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-20.95 54.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-24.98 53.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.70 0.86 0.89 0.83 0.77 0.40 0.39 0.40 0.37 0.36 0.36
Accounts Receivable Turnover
156.82 164.03 110.48 93.17 56.40 34.36 11.96 7.22 3.95 2.24 1.54
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
33.86 36.38 26.38 26.96 38.08 17.31 16.87 26.25 40.32 51.95 53.69
Accounts Payable Turnover
4.12 8.67 8.93 9.73 10.82 8.04 3.72 2.47 1.34 0.86 0.64
Days Sales Outstanding (DSO)
2.33 2.23 3.30 3.92 6.47 10.62 30.51 50.54 92.38 162.71 236.81
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
88.60 42.12 40.86 37.52 33.73 45.40 98.07 148.04 272.96 424.05 574.56
Cash Conversion Cycle (CCC)
-86.28 -39.89 -37.55 -33.60 -27.26 -34.78 -67.56 -97.50 -180.58 -261.34 -337.75
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-7.10 -8.79 -12 -23 -26 -43 -56 -74 -85 -92 -108
Invested Capital Turnover
-1.08 -1.31 -1.44 -1.33 -1.41 -0.70 -0.60 -0.59 -0.60 -0.66 -0.82
Increase / (Decrease) in Invested Capital
0.77 -1.69 -3.54 -10 -3.49 -17 -13 -18 -11 -7.04 -17
Enterprise Value (EV)
1.83 -1.37 -6.89 123 441 175 14 45 38 39 126
Market Capitalization
10 10 10 155 486 231 83 135 148 162 283
Book Value per Share
$0.03 $0.07 $0.12 $0.21 $0.41 $0.27 $0.25 $0.31 $0.46 $0.57 $0.88
Tangible Book Value per Share
$0.00 $0.03 $0.08 $0.16 $0.33 $0.19 $0.17 $0.20 $0.30 $0.34 $0.39
Total Capital
1.35 2.85 4.84 8.89 19 13 13 16 24 30 56
Total Debt
0.17 0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.00
Total Long-Term Debt
0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.14
Net Debt
-8.28 -11 -17 -32 -46 -56 -69 -90 -109 -122 -157
Capital Expenditures (CapEx)
0.14 0.11 0.71 0.26 1.96 3.26 2.62 3.91 7.05 9.36 8.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-8.30 -11 -15 -26 -32 -49 -62 -81 -99 -110 -139
Debt-free Net Working Capital (DFNWC)
0.15 0.99 2.35 5.88 14 7.38 6.94 9.08 10.00 13 26
Net Working Capital (NWC)
-0.02 0.87 2.35 5.88 14 7.38 6.94 9.08 10.00 13 24
Net Nonoperating Expense (NNE)
2.54 0.06 -0.02 -0.11 -0.50 3.30 0.80 -0.72 -6.92 -2.87 -2.01
Net Nonoperating Obligations (NNO)
-8.28 -11 -17 -32 -46 -56 -69 -90 -109 -122 -157
Total Depreciation and Amortization (D&A)
0.36 0.57 0.88 1.09 1.48 2.12 2.50 2.91 4.03 5.99 8.32
Debt-free, Cash-free Net Working Capital to Revenue
-102.37% -102.16% -97.27% -110.07% -92.14% -201.30% -209.52% -212.49% -210.17% -187.74% -169.96%
Debt-free Net Working Capital to Revenue
1.90% 9.53% 15.41% 25.11% 39.32% 30.58% 23.54% 23.87% 21.15% 21.80% 31.17%
Net Working Capital to Revenue
-0.25% 8.33% 15.41% 25.11% 39.32% 30.58% 23.54% 23.87% 21.15% 21.80% 28.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.06) $0.03 $0.04 $0.06 $0.16 ($0.19) ($0.05) $0.02 $0.12 $0.07 $0.14
Adjusted Weighted Average Basic Shares Outstanding
39.64M 42.88M 43.40M 45.48M 47.44M 49.27M 50.98M 52.05M 52.49M 53.21M 54.43M
Adjusted Diluted Earnings per Share
$0.00 $0.03 $0.04 $0.05 $0.14 ($0.19) ($0.05) $0.02 $0.12 $0.07 $0.13
Adjusted Weighted Average Diluted Shares Outstanding
0.00 43.87M 44.93M 52.35M 54.55M 49.27M 50.98M 52.93M 54.16M 55.59M 59.65M
Adjusted Basic & Diluted Earnings per Share
($0.06) $0.03 $0.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
42.77M 43.19M 43.67M 46.73M 49.01M 50.45M 51.86M 52.46M 52.97M 53.75M 55.19M
Normalized Net Operating Profit after Tax (NOPAT)
-0.01 0.95 1.76 1.73 4.27 -5.57 -1.92 0.31 -0.12 0.94 5.54
Normalized NOPAT Margin
-0.08% 9.13% 11.57% 7.39% 12.32% -23.09% -6.51% 0.82% -0.25% 1.61% 6.76%
Pre Tax Income Margin
-31.45% 12.46% 11.76% 11.02% 18.87% -34.19% -9.20% 2.98% 5.00% 7.09% 12.23%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-73.23 17.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-0.18 17.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-77.26 16.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4.21 16.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.46% 12.97% 4.98%

Quarterly Metrics And Ratios for Paysign

This table displays calculated financial ratios and metrics derived from Paysign's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
52,754,374.00 52,968,374.00 52,978,374.00 53,138,374.00 - 53,747,674.00 54,217,674.00 54,451,888.00 55,042,888.00 55,185,394.00 55,905,773.00
DEI Adjusted Shares Outstanding
52,754,374.00 52,968,374.00 52,978,374.00 53,138,374.00 - 53,747,674.00 54,217,674.00 54,451,888.00 55,042,888.00 55,185,394.00 55,905,773.00
DEI Earnings Per Adjusted Shares Outstanding
0.11 0.01 0.01 0.03 - 0.05 0.03 0.04 0.02 0.10 0.12
Growth Metrics
- - - - - - - - - - -
Revenue Growth
28.93% 30.04% 29.80% 23.03% 14.00% 41.00% 33.12% 41.56% 45.81% 50.76% 48.08%
EBITDA Growth
65.65% 905.74% 403.13% 37.90% 19.74% 317.30% 127.29% 67.25% 87.37% 116.88% 162.83%
EBIT Growth
100.95% 65.22% 119.43% 16.84% -26.53% 1,063.44% 1,043.89% 129.32% 299.33% 167.90% 387.68%
NOPAT Growth
778.51% 67.53% 120.60% 23.39% -80.22% 1,272.68% 946.80% 134.66% 96.39% 145.26% 513.56%
Net Income Growth
688.45% 293.03% 769.29% 30.55% -75.58% 736.67% 99.08% 54.17% -0.75% 110.31% 386.87%
EPS Growth
900.00% 0.00% 0.00% 50.00% -80.00% 400.00% 100.00% 33.33% 0.00% 80.00% 450.00%
Operating Cash Flow Growth
515.88% 155.20% 767.44% -600.48% -38.94% -173.18% -82.28% 133.49% 235.99% 411.37% -64.42%
Free Cash Flow Firm Growth
-23.88% 4.62% 4,179.23% 209.74% -45.53% -270.12% -212.05% -220.41% 133.03% 338.63% 227.23%
Invested Capital Growth
-15.30% -20.27% -53.44% -17.58% -8.29% 30.55% 40.04% 20.88% -18.05% -89.63% -73.64%
Revenue Q/Q Growth
10.40% -3.65% 8.65% 6.45% 2.29% 19.17% 2.58% 13.20% 5.37% 23.22% 0.76%
EBITDA Q/Q Growth
10.69% -43.21% 52.26% 44.09% -3.89% 97.91% -17.07% 6.03% 7.66% 129.09% 0.50%
EBIT Q/Q Growth
7.04% -140.88% 148.65% 448.91% -32.69% 436.05% -42.24% 10.04% 17.21% 259.62% 5.14%
NOPAT Q/Q Growth
383.84% -106.47% 155.26% 612.75% -22.42% 283.75% -50.67% 59.78% -35.07% 379.23% 23.41%
Net Income Q/Q Growth
410.85% -94.50% 125.53% 106.12% -4.45% 88.37% -46.34% 59.62% -38.49% 299.15% 24.23%
EPS Q/Q Growth
400.00% -90.00% 0.00% 200.00% -33.33% 150.00% -60.00% 100.00% -50.00% 350.00% 22.22%
Operating Cash Flow Q/Q Growth
481.84% -64.83% 149.28% -198.11% 170.99% -142.15% 160.35% 85.46% 612.20% -60.94% -93.10%
Free Cash Flow Firm Q/Q Growth
217.65% 7.99% 148.73% -65.27% -41.60% -437.24% -63.83% 62.68% 213.02% 245.35% -12.65%
Invested Capital Q/Q Growth
-21.60% -5.89% -18.72% 23.08% -11.99% 32.09% -2.50% -1.50% -67.10% -9.08% 6.14%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.16% 52.61% 52.93% 55.54% 58.94% 62.86% 61.62% 56.26% 57.66% 64.98% 63.35%
EBITDA Margin
13.22% 7.79% 10.92% 14.78% 13.89% 23.07% 18.65% 17.47% 17.85% 33.18% 33.10%
Operating Margin
4.62% -1.96% 0.88% 4.52% 2.98% 13.38% 7.54% 7.33% 8.15% 23.78% 24.82%
EBIT Margin
4.62% -1.96% 0.88% 4.52% 2.98% 13.38% 7.54% 7.33% 8.15% 23.78% 24.82%
Profit (Net Income) Margin
41.07% 2.34% 4.86% 9.42% 8.80% 13.91% 7.27% 10.26% 5.99% 19.40% 23.92%
Tax Burden Percent
412.60% 65.35% 74.24% 96.40% 111.11% 79.54% 67.94% 98.64% 54.64% 72.82% 85.47%
Interest Burden Percent
215.62% -183.08% 747.18% 216.07% 266.10% 130.62% 142.10% 141.95% 134.48% 112.01% 112.75%
Effective Tax Rate
-312.60% 34.65% 25.76% 3.60% -11.11% 20.46% 32.06% 1.36% 45.36% 27.18% 14.53%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
31.68% 33.35% 35.65% 34.56% 13.89% 18.82% 19.65% 20.36% 19.13% 22.07% 30.82%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
1.71% -0.68% 0.32% 1.84% 1.07% 4.52% 2.75% 2.91% 2.94% 8.40% 9.78%
Return on Assets (ROA)
15.24% 0.82% 1.79% 3.82% 3.15% 4.69% 2.65% 4.08% 2.16% 6.85% 9.42%
Return on Common Equity (ROCE)
31.68% 33.35% 35.65% 34.56% 13.89% 18.82% 19.65% 20.36% 19.13% 22.07% 30.82%
Return on Equity Simple (ROE_SIMPLE)
0.00% 27.21% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
2.61 -0.17 0.09 0.66 0.52 1.98 0.98 1.56 1.01 4.86 5.99
NOPAT Margin
19.05% -1.28% 0.65% 4.36% 3.31% 10.65% 5.12% 7.23% 4.45% 17.32% 21.21%
Net Nonoperating Expense Percent (NNEP)
3.03% 0.46% 0.55% 0.78% 0.74% 0.56% 0.34% 0.59% 0.25% 0.42% 0.55%
Return On Investment Capital (ROIC_SIMPLE)
10.65% -0.66% 0.35% 2.33% 1.69% 4.03% 1.96% 2.91% 1.79% 7.94% 9.16%
Cost of Revenue to Revenue
47.84% 47.39% 47.07% 44.46% 41.06% 37.14% 38.38% 43.74% 42.34% 35.02% 36.65%
SG&A Expenses to Revenue
38.94% 44.82% 42.01% 40.76% 45.05% 39.79% 42.97% 38.79% 39.81% 31.79% 30.25%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
47.54% 54.57% 52.05% 51.02% 55.97% 49.48% 54.08% 48.94% 49.51% 41.20% 38.53%
Earnings before Interest and Taxes (EBIT)
0.63 -0.26 0.13 0.69 0.46 2.49 1.44 1.58 1.85 6.67 7.01
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.81 1.03 1.57 2.26 2.17 4.29 3.56 3.77 4.06 9.30 9.35
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.03 7.61 8.50 6.84 5.31 2.90 9.25 7.49 5.85 5.92 7.61
Price to Tangible Book Value (P/TBV)
9.42 12.41 14.15 11.51 8.88 13.23 27.81 19.10 13.09 11.29 13.15
Price to Revenue (P/Rev)
3.12 3.85 4.26 3.45 2.77 1.79 5.70 4.57 3.46 3.56 4.55
Price to Earnings (P/E)
22.87 27.98 29.54 24.18 42.38 18.70 57.55 45.29 37.54 31.29 29.03
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.37% 3.57% 3.39% 4.14% 2.36% 5.35% 1.74% 2.21% 2.66% 3.20% 3.44%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.81 1.56 1.77 1.50 0.67 0.19 4.15 3.10 1.54 1.66 2.85
Enterprise Value to EBITDA (EV/EBITDA)
9.94 16.41 15.70 12.68 5.61 1.19 23.16 16.81 8.07 7.36 10.82
Enterprise Value to EBIT (EV/EBIT)
0.00 247.62 87.00 71.02 38.54 3.25 55.93 38.81 17.18 13.19 16.75
Enterprise Value to NOPAT (EV/NOPAT)
0.00 107.06 44.80 37.56 41.80 3.69 66.13 45.04 22.83 18.07 21.36
Enterprise Value to Operating Cash Flow (EV/OCF)
1.39 2.41 1.68 2.63 1.72 1.41 0.00 12.41 2.41 1.97 3.83
Enterprise Value to Free Cash Flow (EV/FCFF)
3.55 4.95 2.41 5.82 4.93 0.00 0.00 0.00 5.72 2.37 4.74
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.25 0.18 0.17 0.17 0.11 0.09
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.20 0.15 0.13 0.13 0.08 0.06
Financial Leverage
-4.89 -4.96 -5.06 -4.25 -4.22 -3.35 -3.47 -2.98 -3.54 -2.92 -2.71
Leverage Ratio
6.25 6.94 6.71 5.96 5.93 5.84 5.45 5.07 5.77 5.49 4.99
Compound Leverage Factor
13.47 -12.71 50.17 12.88 15.78 7.63 7.74 7.20 7.76 6.15 5.63
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 19.98% 15.49% 14.67% 14.17% 10.04% 8.03%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 4.07% 3.20% 3.22% 3.30% 2.59% 2.58%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 15.91% 12.29% 11.45% 10.87% 7.45% 5.45%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 80.02% 84.51% 85.33% 85.83% 89.96% 91.97%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.95 0.63 0.57 0.51 0.30 0.20
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -9.89 -8.65 -8.03 -10.01 -8.38 -6.46
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.76 0.50 0.45 0.39 0.22 0.13
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 2.95 1.80 1.53 1.44 0.73 0.39
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -30.63 -24.71 -21.50 -28.33 -20.57 -12.76
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 2.35 1.43 1.19 1.11 0.54 0.27
Altman Z-Score
1.18 1.18 1.28 1.33 1.13 0.90 2.10 1.84 1.25 1.33 1.71
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.08 1.07 1.07 1.09 1.09 1.07 1.11 1.13 1.11 1.12 1.14
Quick Ratio
0.29 0.30 0.38 0.33 0.31 0.39 0.38 0.38 0.43 0.46 0.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
14 15 37 13 7.55 -25 -42 -16 18 61 53
Operating Cash Flow to CapEx
1,144.17% 383.38% 868.29% -823.70% 597.42% -247.92% 202.35% 318.50% 2,900.75% 1,121.31% 90.23%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.37 0.35 0.37 0.41 0.36 0.34 0.36 0.40 0.36 0.35 0.39
Accounts Receivable Turnover
3.95 2.10 2.95 2.62 2.24 1.41 1.96 1.77 1.54 1.24 1.38
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
40.32 44.89 48.04 49.36 51.95 58.40 61.57 57.82 53.69 58.22 65.64
Accounts Payable Turnover
1.34 1.02 0.84 1.12 0.86 0.63 0.61 0.80 0.64 0.53 0.57
Days Sales Outstanding (DSO)
92.38 173.45 123.87 139.57 162.71 258.53 185.81 206.75 236.81 294.36 263.93
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
272.96 356.31 432.77 325.51 424.05 578.21 597.21 453.71 574.56 687.48 637.63
Cash Conversion Cycle (CCC)
-180.58 -182.85 -308.90 -185.94 -261.34 -319.68 -411.40 -246.96 -337.75 -393.12 -373.70
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-85 -90 -107 -82 -92 -62 -64 -65 -108 -118 -111
Invested Capital Turnover
-0.60 -0.61 -0.61 -0.74 -0.66 -0.84 -0.80 -1.02 -0.82 -1.01 -1.15
Increase / (Decrease) in Invested Capital
-11 -15 -37 -12 -7.04 27 43 17 -17 -56 -47
Enterprise Value (EV)
38 79 95 84 39 12 284 232 126 152 287
Market Capitalization
148 194 228 195 162 114 390 343 283 326 458
Book Value per Share
$0.46 $0.48 $0.51 $0.54 $0.57 $0.73 $0.78 $0.84 $0.88 $1.00 $1.08
Tangible Book Value per Share
$0.30 $0.29 $0.30 $0.32 $0.34 $0.16 $0.26 $0.33 $0.39 $0.52 $0.62
Total Capital
24 25 27 29 30 49 50 54 56 61 65
Total Debt
0.00 0.00 0.00 0.00 0.00 9.81 7.74 7.87 8.00 6.14 5.25
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 7.81 6.14 6.14 6.14 4.55 3.56
Net Debt
-109 -115 -134 -111 -122 -102 -106 -111 -157 -173 -171
Capital Expenditures (CapEx)
2.05 2.15 2.37 2.45 2.40 2.43 1.80 2.12 1.66 1.68 1.44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-99 -105 -123 -99 -110 -98 -97 -98 -139 -149 -140
Debt-free Net Working Capital (DFNWC)
10.00 10 11 12 13 13 17 21 26 31 36
Net Working Capital (NWC)
10.00 10 11 12 13 11 15 19 24 29 35
Net Nonoperating Expense (NNE)
-3.01 -0.48 -0.60 -0.77 -0.86 -0.61 -0.41 -0.65 -0.35 -0.58 -0.76
Net Nonoperating Obligations (NNO)
-109 -115 -134 -111 -122 -102 -106 -111 -157 -173 -171
Total Depreciation and Amortization (D&A)
1.18 1.29 1.44 1.57 1.70 1.80 2.12 2.19 2.21 2.64 2.34
Debt-free, Cash-free Net Working Capital to Revenue
-210.17% -209.18% -229.17% -175.20% -187.74% -153.65% -141.41% -130.39% -169.96% -162.53% -139.32%
Debt-free Net Working Capital to Revenue
21.15% 20.00% 19.91% 20.60% 21.80% 21.12% 24.79% 27.93% 31.17% 33.71% 36.03%
Net Working Capital to Revenue
21.15% 20.00% 19.91% 20.60% 21.80% 17.99% 22.46% 25.63% 28.90% 31.97% 34.36%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.10 $0.01 $0.01 $0.03 $0.02 $0.05 $0.03 $0.04 $0.02 $0.10 $0.12
Adjusted Weighted Average Basic Shares Outstanding
52.49M 52.84M 53.01M 53.45M 53.21M 53.58M 54.23M 54.80M 54.43M 55.17M 55.86M
Adjusted Diluted Earnings per Share
$0.10 $0.01 $0.01 $0.03 $0.02 $0.05 $0.02 $0.04 $0.02 $0.09 $0.11
Adjusted Weighted Average Diluted Shares Outstanding
54.16M 54.76M 55.86M 56.05M 55.59M 55.14M 57.87M 61.77M 59.65M 61.02M 61.98M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
52.97M 52.98M 53.14M 53.55M 53.75M 54.22M 54.45M 55.04M 55.19M 55.91M 56.46M
Normalized Net Operating Profit after Tax (NOPAT)
0.44 -0.17 0.09 0.66 0.33 1.98 0.98 1.56 1.01 4.86 5.99
Normalized NOPAT Margin
3.23% -1.28% 0.65% 4.36% 2.08% 10.65% 5.12% 7.23% 4.45% 17.32% 21.21%
Pre Tax Income Margin
9.95% 3.59% 6.55% 9.77% 7.92% 17.48% 10.71% 10.40% 10.96% 26.64% 27.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
17.46% 6.67% 1.94% 4.47% 12.97% 14.29% 12.84% 6.75% 4.98% 1.92% 0.00%

Financials Breakdown Chart

Key Financial Trends

Paysign’s financial performance has strengthened significantly since 2023. Quarterly revenue increased from $12.4 million in Q3 2023 to $28.3 million in Q2 2026. On a year-over-year basis, Q2 2026 revenue rose approximately 48% from $19.1 million in Q2 2025. Revenue also edged higher from $28.0 million in Q1 2026, indicating continued momentum, although the sequential increase was modest.

Profitability has improved even more rapidly than revenue. Q2 2026 gross profit was $17.9 million, producing a gross margin of approximately 63.3%, compared with 61.6% in Q2 2025. Operating income increased to $7.0 million from $1.4 million a year earlier, lifting the operating margin to approximately 24.8%. Net income rose to $6.8 million, compared with $1.4 million in Q2 2025. This continues a broader improvement from the sub-$1 million quarterly earnings reported in several 2024 periods.

However, cash-flow performance was less consistent. Paysign generated $1.3 million of operating cash flow in Q2 2026, down from $3.6 million in Q2 2025 and $18.8 million in Q1 2026. The company still produced positive operating cash flow, but the gap between reported net income and operating cash flow in the latest quarter highlights the importance of monitoring working-capital movements and noncash adjustments.

The balance sheet remains relatively liquid, though much of the liquidity is restricted. At June 30, 2026, Paysign reported $27.4 million of cash and equivalents and $149.1 million of restricted cash. Total current assets were $283.0 million versus $248.4 million of current liabilities, implying a current ratio of approximately 1.14. Total debt was only about $5.3 million, while shareholders’ equity increased to $60.2 million from $42.2 million in Q2 2025.

Investors should also note the company’s unusual liability structure. Current deferred revenue reached $148.2 million and accounts payable totaled $97.7 million in Q2 2026. These balances support liquidity today, but they also represent obligations that must be converted into services or settled as the business grows. Accounts receivable increased to $103.2 million, making collections and working-capital management important factors for future cash generation.

  • Strong revenue growth: Q2 2026 revenue increased approximately 48% year over year and more than doubled from Q3 2023 levels.
  • Expanding margins: Gross margin improved to approximately 63.3%, while operating margin expanded to about 24.8% in Q2 2026.
  • Higher earnings: Q2 2026 net income of $6.8 million was substantially above the $1.4 million reported in Q2 2025, with diluted EPS increasing to $0.11 from $0.02.
  • Low leverage: Total short- and long-term debt was approximately $5.3 million against more than $316.9 million of total assets.
  • Improved equity position: Shareholders’ equity increased approximately 43% year over year to $60.2 million, supported by rising retained earnings.
  • Positive but volatile operating cash flow: Paysign generated operating cash flow in each reported 2025 and 2026 quarter, but quarterly results ranged from $1.3 million to $48.1 million.
  • Meaningful investment spending: Capital expenditures were approximately $1.4 million in Q2 2026 and have generally remained near $1.7 million to $2.4 million per quarter.
  • Restricted liquidity: Approximately $149.1 million of the company’s $176.5 million in cash and restricted cash was classified as restricted, limiting its immediate flexibility.
  • Working-capital exposure: Accounts receivable rose to $103.2 million, while current deferred revenue and accounts payable together exceeded $245 million.
  • Share dilution remains a concern: Basic weighted-average shares increased to 55.9 million in Q2 2026 from 53.2 million in Q2 2024, while diluted shares were approximately 62.0 million in the latest quarter.

Overall, Paysign’s income statement shows a favorable multi-year trend of accelerating revenue, expanding margins and stronger earnings. The main questions for investors are whether the company can convert those profits into more consistent operating cash flow, reduce its reliance on restricted funds and manage its growing receivables and deferred-revenue obligations without further share dilution.

10/15/26 04:30 PM ETAI Generated. May Contain Errors.

Paysign Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Paysign's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Paysign's net income appears to be on an upward trend, with a most recent value of $7.55 million in 2025, compared with -$2.55 million in 2015. The previous period was $3.82 million in 2024. View Paysign's forecast to see where analysts expect Paysign to go next.

Paysign's total operating income in 2025 was $7.36 million, based on the following breakdown:
  • Total Gross Profit: $48.72 million
  • Total Operating Expenses: $41.35 million

Over the last 10 years, Paysign's total revenue changed from $8.11 million in 2015 to $82.03 million in 2025, a change of 911.8%.

In the past 11 quarters, Paysign's cash and equivalents has ranged from $6.85 million in Q1 2025 to $31.29 million in Q2 2024, and is currently $27.37 million as of their latest financial filing in Q2 2026.

Paysign had total debt of $8.00 million at the end of 2025, compared with none in 2024, and a 4,497.3% increase since 2015.

Over the last 10 years, Paysign's book value per share changed from 0.03 in 2015 to 0.88 in 2025, a change of 2,846.5%.



Financial statements for NASDAQ:PAYS last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners